New dengue drug trial aims to stop virus in its tracks

NCT ID NCT06551844

First seen May 10, 2026 · Last updated May 17, 2026 · Updated 2 times

Summary

This study tests experimental antiviral drugs in people with early dengue fever (less than 48 hours of symptoms). The goal is to see if these drugs can lower the amount of virus in the blood and reduce illness severity. About 500 participants will be enrolled and closely monitored for safety and recovery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DENGUE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hospital for Tropical Diseases, Ho Chi Minh city

    RECRUITING

    Ho Chi Minh City, 700000, Vietnam

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

  • Universiti Malaya Medical Centre

    NOT_YET_RECRUITING

    Kuala Lumpur, 59100, Malaysia

    Contact

Conditions

Explore the condition pages connected to this study.